Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine

Charles Lawrence Loprinzi, Patrick J. Flynn, Lisa A. Carpenter, Pam Atherton, Debra L. Barton, Tait D. Shanafelt, Teresa A. Rummans, Jeff A Sloan, Alex Adjei, Betty A. Mincey, Tom R. Fitch, Mary Collins

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: While newer antidepressants, such as venlafaxine and paroxetine, substantially decrease hot flashes, there is no published information with regards to whether a different antidepressant will be effective when one antidepressant does not adequately relieve hot flashes. Objective: The objective of this trial was to provide pilot information with regards to whether citalopram would effectively reduce hot flashes in patients who did not receive adequate enough hot flash reduction with venlafaxine. Design: This was a prospective pilot trial Measurements: Validated patient-completed hot flash diary questionnaires were utilized for measuring hot flashes. Subjects: Thirty patients were recruited to this trial, 22 of whom were fully evaluable. Results: Compared to a baseline week, hot flash scores were reduced by 53% 4 weeks later. The citalopram appeared to be well tolerated with many quality-of-life and potential toxicity symptoms much improved compared to the baseline week. At the end of the 4-week treatment, 19 patients (63% of patients entering the study and 86% of the patient completing the study treatment) chose to continue to use citalopram. Conclusion: This pilot information supports the hypothesis that citalopram will reduce hot flashes in patients with inadequate hot flash relief while taking venlafaxine.

Original languageEnglish (US)
Pages (from-to)924-930
Number of pages7
JournalJournal of Palliative Medicine
Volume8
Issue number5
DOIs
StatePublished - Oct 2005

Fingerprint

Hot Flashes
Citalopram
Antidepressive Agents
Therapeutics
Venlafaxine Hydrochloride
Paroxetine
Quality of Life

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. / Loprinzi, Charles Lawrence; Flynn, Patrick J.; Carpenter, Lisa A.; Atherton, Pam; Barton, Debra L.; Shanafelt, Tait D.; Rummans, Teresa A.; Sloan, Jeff A; Adjei, Alex; Mincey, Betty A.; Fitch, Tom R.; Collins, Mary.

In: Journal of Palliative Medicine, Vol. 8, No. 5, 10.2005, p. 924-930.

Research output: Contribution to journalArticle

Loprinzi, CL, Flynn, PJ, Carpenter, LA, Atherton, P, Barton, DL, Shanafelt, TD, Rummans, TA, Sloan, JA, Adjei, A, Mincey, BA, Fitch, TR & Collins, M 2005, 'Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine', Journal of Palliative Medicine, vol. 8, no. 5, pp. 924-930. https://doi.org/10.1089/jpm.2005.8.924
Loprinzi, Charles Lawrence ; Flynn, Patrick J. ; Carpenter, Lisa A. ; Atherton, Pam ; Barton, Debra L. ; Shanafelt, Tait D. ; Rummans, Teresa A. ; Sloan, Jeff A ; Adjei, Alex ; Mincey, Betty A. ; Fitch, Tom R. ; Collins, Mary. / Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. In: Journal of Palliative Medicine. 2005 ; Vol. 8, No. 5. pp. 924-930.
@article{9e3d9170b7154b97bd43e30174f87557,
title = "Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine",
abstract = "Background: While newer antidepressants, such as venlafaxine and paroxetine, substantially decrease hot flashes, there is no published information with regards to whether a different antidepressant will be effective when one antidepressant does not adequately relieve hot flashes. Objective: The objective of this trial was to provide pilot information with regards to whether citalopram would effectively reduce hot flashes in patients who did not receive adequate enough hot flash reduction with venlafaxine. Design: This was a prospective pilot trial Measurements: Validated patient-completed hot flash diary questionnaires were utilized for measuring hot flashes. Subjects: Thirty patients were recruited to this trial, 22 of whom were fully evaluable. Results: Compared to a baseline week, hot flash scores were reduced by 53{\%} 4 weeks later. The citalopram appeared to be well tolerated with many quality-of-life and potential toxicity symptoms much improved compared to the baseline week. At the end of the 4-week treatment, 19 patients (63{\%} of patients entering the study and 86{\%} of the patient completing the study treatment) chose to continue to use citalopram. Conclusion: This pilot information supports the hypothesis that citalopram will reduce hot flashes in patients with inadequate hot flash relief while taking venlafaxine.",
author = "Loprinzi, {Charles Lawrence} and Flynn, {Patrick J.} and Carpenter, {Lisa A.} and Pam Atherton and Barton, {Debra L.} and Shanafelt, {Tait D.} and Rummans, {Teresa A.} and Sloan, {Jeff A} and Alex Adjei and Mincey, {Betty A.} and Fitch, {Tom R.} and Mary Collins",
year = "2005",
month = "10",
doi = "10.1089/jpm.2005.8.924",
language = "English (US)",
volume = "8",
pages = "924--930",
journal = "Journal of Palliative Medicine",
issn = "1096-6218",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine

AU - Loprinzi, Charles Lawrence

AU - Flynn, Patrick J.

AU - Carpenter, Lisa A.

AU - Atherton, Pam

AU - Barton, Debra L.

AU - Shanafelt, Tait D.

AU - Rummans, Teresa A.

AU - Sloan, Jeff A

AU - Adjei, Alex

AU - Mincey, Betty A.

AU - Fitch, Tom R.

AU - Collins, Mary

PY - 2005/10

Y1 - 2005/10

N2 - Background: While newer antidepressants, such as venlafaxine and paroxetine, substantially decrease hot flashes, there is no published information with regards to whether a different antidepressant will be effective when one antidepressant does not adequately relieve hot flashes. Objective: The objective of this trial was to provide pilot information with regards to whether citalopram would effectively reduce hot flashes in patients who did not receive adequate enough hot flash reduction with venlafaxine. Design: This was a prospective pilot trial Measurements: Validated patient-completed hot flash diary questionnaires were utilized for measuring hot flashes. Subjects: Thirty patients were recruited to this trial, 22 of whom were fully evaluable. Results: Compared to a baseline week, hot flash scores were reduced by 53% 4 weeks later. The citalopram appeared to be well tolerated with many quality-of-life and potential toxicity symptoms much improved compared to the baseline week. At the end of the 4-week treatment, 19 patients (63% of patients entering the study and 86% of the patient completing the study treatment) chose to continue to use citalopram. Conclusion: This pilot information supports the hypothesis that citalopram will reduce hot flashes in patients with inadequate hot flash relief while taking venlafaxine.

AB - Background: While newer antidepressants, such as venlafaxine and paroxetine, substantially decrease hot flashes, there is no published information with regards to whether a different antidepressant will be effective when one antidepressant does not adequately relieve hot flashes. Objective: The objective of this trial was to provide pilot information with regards to whether citalopram would effectively reduce hot flashes in patients who did not receive adequate enough hot flash reduction with venlafaxine. Design: This was a prospective pilot trial Measurements: Validated patient-completed hot flash diary questionnaires were utilized for measuring hot flashes. Subjects: Thirty patients were recruited to this trial, 22 of whom were fully evaluable. Results: Compared to a baseline week, hot flash scores were reduced by 53% 4 weeks later. The citalopram appeared to be well tolerated with many quality-of-life and potential toxicity symptoms much improved compared to the baseline week. At the end of the 4-week treatment, 19 patients (63% of patients entering the study and 86% of the patient completing the study treatment) chose to continue to use citalopram. Conclusion: This pilot information supports the hypothesis that citalopram will reduce hot flashes in patients with inadequate hot flash relief while taking venlafaxine.

UR - http://www.scopus.com/inward/record.url?scp=27644489766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644489766&partnerID=8YFLogxK

U2 - 10.1089/jpm.2005.8.924

DO - 10.1089/jpm.2005.8.924

M3 - Article

C2 - 16238505

AN - SCOPUS:27644489766

VL - 8

SP - 924

EP - 930

JO - Journal of Palliative Medicine

JF - Journal of Palliative Medicine

SN - 1096-6218

IS - 5

ER -